Medical Photonics

Medical Photonics Limited is a spin-out company from the University of Nottingham that develops and commercializes fibre optic technologies for medical diagnostics, monitoring, and treatment. Formed in December 2024, the company leverages expertise in optical fibre sensing to create smart medical devices and innovations. The founding team consists of academics from the University of Nottingham's Faculty of Engineering and an experienced external chairperson and clinician. The team includes CEO Steve Morgan, who has 30 years of experience in opto-electronics and medical devices; COO Brett Gadsby; Medical Director Dr. Andrew Norris; and directors Serhiy Korposh and Ricardo Correia, who specialize in photonics instrumentation and fibre optic sensing respectively. David Whelan serves as the Chairman, and Professor Barrie Hayes-Gill, a specialist in electronic medical instrumentation, is the Vice-Chairman.

The company's core business revolves around translating laboratory research in optical fibre sensing into practical medical applications to improve patient outcomes. It collaborates with the University of Nottingham and its clinical partners to commercialize these technologies. The products under development utilize optical systems combined with embedded AI and machine learning to enable precise diagnostics and physiological monitoring. The firm's focus is on bridging the gap between academic research and real-world healthcare applications, ensuring the technologies are designed to meet clinical needs.

Keywords: optical fibre sensing, medical diagnostics, physiological monitoring, medtech, fibre optics, healthcare technology, biophotonics, medical devices, minimally invasive diagnostics, clinical commercialization, smart medical devices, AI in healthcare, machine learning in diagnostics, University of Nottingham spin-out, patient monitoring, laser surgery, non-invasive diagnostics, advanced imaging, therapeutic applications, medical instrumentation